LRG1 Antikörper (AA 37-347)
Kurzübersicht für LRG1 Antikörper (AA 37-347) (ABIN530410)
Target
Alle LRG1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 37-347
-
Verwendungszweck
- Mouse monoclonal antibody raised against a full length recombinant LRG1.
-
Sequenz
- TLSPKDCQVF RPDHGSSISC QPPAEIPGYL PADTVHLAVE FFNLTHLPAN LLQGASKLQE LHLSSNGLES LSPEFLRPVP QLRVLDLTRN ALTGLPSGLF QASATLDTLV LKENQLEVLE VSWLHGLKAL GHLDLSGNRL RKLPPGLLAN FTLLRTLDLG ENQLETLPPD LLRGPLQLER LHLEGNKLQV LGKDLLLPQP DLRYLFLNGN KLARVAAGAF QGLRQLDMLD LSNNSLASVP EGLWASLGQP NWDMRDGFDI SGNPWICDQN LSDLYRWLQA QRDKMFSQND TRCAGPEAVK GQTLLAVAKS Q
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- LRG1 (AAH34389, 37 a.a. ~ 347 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Proteomic profiling for the identification of serum diagnostic biomarkers for abdominal and thoracic aortic aneurysms." in: Proteome science, Vol. 11, Issue 1, pp. 27, (2013) (PubMed).
: "MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-? signalling pathway." in: Carcinogenesis, Vol. 33, Issue 5, pp. 976-85, (2012) (PubMed).
-
-
- LRG1 (Leucine-Rich alpha-2 Glycoprotein 1 (LRG1))
-
Andere Bezeichnung
- LRG1
-
Hintergrund
-
Full Gene Name: leucine-rich alpha-2-glycoprotein 1
Synonyms: HMFT1766,LRG -
Gen-ID
- 116844
-
Pathways
- Brown Fat Cell Differentiation
Target
-